Envision Pharma Group acquires Cambridge artificial intelligence company
Envision Pharma Group has acquired Cambridge artificial intelligence technology company OKRA.ai for an undisclosed sum.
Envision is a leading tech-enabled commercialisation, integrated medical capabilities and solutions and data analytics partner to the life sciences industry worldwide.
OKRA.ai, has services across commercialisation, real-world evidence and data analytics, medical, and pricing for the pharmaceutical and life sciences sector.
OKRA’s AI products and solutions translate large clinical, scientific, and commercial data sets into actionable insights to empower decision-making and positive outcomes to clients in the life sciences industry.
“We are delighted to welcome OKRA.ai into the Envision family,” says Meg Heim, CEO, Envision Pharma Group.
“The acquisition of OKRA.ai marks an exciting milestone in Envision’s evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients.
“The combination of Envision’s leading technology, capabilities, and solutions with OKRA.ai’s artificial intelligence expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly support patients in their journey to health and wellness.”
Dr Loubna Bouarfa, founder of OKRA.ai, will be joining Envision as a member of its executive leadership team. Recently she won the Deloitte Fast 50 Women in Leadership Award and Forbes 50 Top Women in Tech.
She says: “Today is a redefining moment for OKRA.ai. I am honoured to be joining forces with Envision and to see the enormous opportunities for the growth of our combined expertise and solutions for clients in the life sciences industry.
“As part of Envision Pharma Group, we can accelerate our work to bring AI to the heart of decision-making across the life sciences industry. Our success will not only bring commercial benefit to clients, but lead to improved patient outcomes across the globe.”
Based in the UK and Netherlands, OKRA.ai employs around 30 people. The acquisition of OKRA.ai will bring the Envision Pharma Group headcount to 1400+ employees across four continents.